Diagnos Laboratorium Utama Tbk. vs Pancaran Samudera Transport Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Pancaran Samudera Transport Tbk. trades at Rp890 (market cap 1.31T, 179.6K 24h volume). The key difference: Pancaran Samudera Transport Tbk. is far larger — about 4.1× Diagnos Laboratorium Utama Tbk.'s market cap, and Pancaran Samudera Transport Tbk. is more actively traded (179.6K versus 41.7K). Which is the better fit depends on your goals.
| DGNS | PSAT | |
|---|---|---|
Market Cap | 316.25B | 1.31T |
Volume | 41.7K | 179.6K |
Lot | 417 | 1.8K |
Turnover | 9.66M | 157.1M |
Average Price | 231.65 | 874.73 |
Value | 9.66M | 157.1M |
Indicative Equilibrium Price | 230 | 890 |
Indicative Equilibrium Volume | 2.4K | 2 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Pancaran Samudera Transport Tbk (the Company) was established on December 10, 2007 in the Republic of Indonesia based on the Notarial Deed No. 1 from Mary Maria, S.H, Notary in Depok. The Company commenced its operations in 2007. The Companys immediate parent company is PT Profitama Hasil Indah, incorporated and domiciled in Indonesia and its ultimate parent company is PT Pancaran Harapan Integra, also incorporated and domiciled in Indonesia.
Read more on PSAT →